Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hunt

Showing results (711-720 of 886) with videos related to

Pageof 89
Sort By:
The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.
JCI Insight|February 12, 2020
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapyMichael J Peluso, Peter Bacchetti, Kristen D Ritter, et al.
Blood|December 26, 2008
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune controlApril L Ferre, Peter W Hunt, J William Critchfield, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 21, 2018
Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In SituJoshua J Vasquez, Rajaa Hussien, Brandon Aguilar-Rodriguez, et al.
AIDS (London, England)|September 10, 2003
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapyPeter W Hunt, Steven G Deeks, Benigno Rodriguez, et al.
Plos One|October 2, 2019
Pneumoproteins are associated with pulmonary function in HIV-infected personsDiane Jeon, Emily G Chang, Maggie McGing, et al.
Frontiers in Immunology|November 17, 2022
Anakinra Pilot - a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infantsElys A Green, David Metz, Robert Galinsky, et al.
AIDS (London, England)|April 10, 2020
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical eventsSara Gianella, Carlee Moser, Andrej Vitomirov, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 27, 2021
Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorderHaixia Zheng, Maurizio Bergamino, Bart N Ford, et al.
AIDS (London, England)|July 24, 2010
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individualsHiroyu Hatano, Eric L Delwart, Philip J Norris, et al.
Pageof 89

Showing results (711-720 of 886) with videos related to

Sort By:
Pageof 89
The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.
JCI Insight|February 12, 2020
Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapyMichael J Peluso, Peter Bacchetti, Kristen D Ritter, et al.
Blood|December 26, 2008
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune controlApril L Ferre, Peter W Hunt, J William Critchfield, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 21, 2018
Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In SituJoshua J Vasquez, Rajaa Hussien, Brandon Aguilar-Rodriguez, et al.
AIDS (London, England)|September 10, 2003
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapyPeter W Hunt, Steven G Deeks, Benigno Rodriguez, et al.
Plos One|October 2, 2019
Pneumoproteins are associated with pulmonary function in HIV-infected personsDiane Jeon, Emily G Chang, Maggie McGing, et al.
Frontiers in Immunology|November 17, 2022
Anakinra Pilot - a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infantsElys A Green, David Metz, Robert Galinsky, et al.
AIDS (London, England)|April 10, 2020
Presence of asymptomatic cytomegalovirus and Epstein--Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical eventsSara Gianella, Carlee Moser, Andrej Vitomirov, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 27, 2021
Replicable association between human cytomegalovirus infection and reduced white matter fractional anisotropy in major depressive disorderHaixia Zheng, Maurizio Bergamino, Bart N Ford, et al.
AIDS (London, England)|July 24, 2010
Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individualsHiroyu Hatano, Eric L Delwart, Philip J Norris, et al.
Pageof 89